Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025
Market Cap 1 91.84
Change -
Enterprise Value (EV) 1 61.1
Change -
P/E 21.2x
PBR 1.04x
PEG -1.1x
Capitalization / Revenue 1.12x
EV / Revenue 0.74x
EV / EBITDA 7.34x
EV / EBIT 16x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 1.896
Distribution rate -
Net sales 1 82.35
EBITDA 1 8.319
EBIT 1 3.821
Net income 1 3.947
Net Debt 1 -30.75
Reference price 2 40.24
Nbr of stocks (in thousands) 2,282
Announcement Date 8/26/25 A
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 991K
-151.43x12.54x-170.73x-.--% 36.12B
21.85x2.07x11.9x0.93% 25.77B
17.9x1.38x7.83x4.93% 7.59B
324.21x - - - 4.97B
48.63x8.95x30.84x1.03% 3.16B
-18.5x - - - 1.84B
32.38x1.61x12.28x1.58% 1.82B
13.28x1.36x5.32x5.71% 1.81B
-30.06x - - -.--% 1.74B
Average 28.69x 4.65x -17.09x 2.02% 8.48B
Weighted average by Cap. -35.48x 7.22x -74.37x 1%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited